SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 34357399.
- Also identified by DOI 10.1001/jamanetworkopen.2021.19741 and PMC identifier 8346938.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study examines antibody responses in infection-naive and previously infected individuals after 1 and 2 doses of the BNT162b2 vaccine.
Medical subject headings
- Antibodies, Viral
- Antibody Formation
- COVID-19
- COVID-19 Vaccines
- SARS-CoV-2